UBS Group’s Concorde International Group CIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$974 Sell
1,265
-299
-19% -$324 ﹤0.01% 9679
2026
Q1
$2.78K Sell
1,564
-1,348
-46% -$2.57K ﹤0.01% 9204
2025
Q4
$4.69K Buy
2,912
+826
+40% +$1.91K ﹤0.01% 8797
2025
Q3
$5.84K Buy
+2,086
New +$9.39K ﹤0.01% 8824

Other funds holding CIGL

UBS Group's CIGL Position: Q2 2026 in Review

UBS Group reduced its Concorde International Group (CIGL) stake by 19% in Q2 2026, selling an estimated $324 and leaving 1,265 shares worth $974. The position accounts for ﹤0.01% of the portfolio, ranked #9679.

UBS Group first reported a position in CIGL in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.84K in Q3 2025. 9 funds tracked by Wall St. Rank hold CIGL as of Q2 2026.

  • UBS Group held 1,265 shares of Concorde International Group worth $974 as of Q2 2026.
  • UBS Group sold 299 Concorde International Group shares in Q2 2026, an estimated $324.
  • Concorde International Group made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9679 holding.
  • UBS Group first reported a position in Concorde International Group in Q3 2025 and has held it in 4 quarters since.
  • UBS Group's Concorde International Group position peaked at $5.84K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held Concorde International Group as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.